Delivery Order V797D6023E-VA77017F0478
Award Date
1/23/17
Potential Completion Date
2/2/17
Potential Value
$452K
Funding Federal Agency
Veterans Integrated Service Network 12
Contracting Federal Agency
Veterans Integrated Service Network 15
Awardee
Emergent Devices, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Wayne, PA, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $455,898.24 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Emergent Devices, Inc., a pharmaceutical manufacturer, for the supply of NARCAN nasal spray, a naloxone product used to rapidly reverse opioid overdoses. The contract has an ultimate completion date of August 17, 2016 and was awarded on August 10, 2016 without any set-aside designation. Emergent Devices, a subsidiary of Emergent BioSolutions, is a key supplier of naloxone...
The Department of Veterans Affairs Veterans Health Administration awarded a $904,465.44 firm fixed price delivery order to Emergent Devices, Inc. for the provision of naloxone nasal spray. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. Emergent Devices, a for-profit manufacturer, holds a Federal Supply Schedule 65 IB contract to provide pharmaceuticals and drugs to VA facilities through 2028. This delivery order was placed against that larger contract...
The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Emergent Devices, Inc. for the provision of naloxone nasal spray. The contract is a Firm Fixed Price Delivery Order with a potential value of $292,572.00. Naloxone is a medication that rapidly reverses opioid overdoses and treats substance abuse. Emergent Devices, a for-profit manufacturer, is the prime contractor on this award. The contract is not set aside and is issued under the...
The Department of Veterans Affairs Veterans Health Administration awarded a Delivery Order contract to Emergent Devices, Inc. to provide NALOXONE HCL 4MG/SPRAY SOLN,SPRAY,NASAL. The $857,450.88 Firm Fixed Price contract is under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. Emergent Devices, a for-profit manufacturer, will deliver the opioid overdose reversal medication to VA facilities. This contract supports the VA's healthcare mission, providing a critical substance abuse...
The Department of Veterans Affairs Veterans Health Administration awarded Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, a firm-fixed-price delivery order contract to provide naloxone nasal spray. The $904,465.44 contract is under the Pharmaceuticals and Drugs Federal Supply Schedule 61-IB, which allows Emergent Devices to furnish drugs and hematology products to VA facilities through 2028. The naloxone nasal spray rapidly reverses opioid overdoses and treats substance...
The Department of Veterans Affairs Veterans Health Administration awarded a $672,672.00 Firm Fixed Price Delivery Order to Emergent Devices, Inc., a for-profit manufacturer, for the provision of the opioid overdose reversal medication naloxone. This order is under Emergent Devices' existing Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which runs through August 2028. The contract has no set-aside designation. Emergent Devices has previously received sub-awards from...
This is a $686,400.00 Delivery Order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer of pharmaceutical goods. The contract is part of the VA's Federal Supply Schedule 65 IB for Pharmaceuticals and Drugs, which allows the agency to purchase naloxone nasal spray and other hematology-related products from Emergent Devices through August 2028. Emergent Devices has also received sub-awards from state health...
This is a federal contract award to Emergent Devices, Inc., a for-profit pharmaceutical manufacturer, for the delivery of naloxone nasal spray. The contract, valued at $904,465.44, was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The contract is a delivery order under Emergent Devices' Federal Supply Schedule 65 IB contract for pharmaceuticals and drugs, which runs through August 2028. Naloxone is a medication used to...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Emergent Devices, Inc., a for-profit manufacturer, to provide naloxone nasal spray. The contract is a firm-fixed price order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, with a potential value of $904,465.44. The contract does not have a set-aside designation. Naloxone is a medication that rapidly reverses opioid overdoses and is used to...
This is a federal contract award to Emergent Devices, Inc., a multinational specialty biopharmaceutical company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of naloxone nasal spray, a medication that rapidly reverses opioid overdoses and treats substance abuse. The contract has a potential value of $1,008,582.12 and is a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract does not...